Katie R Mollan

Katie R Mollan

University of North Carolina Chapel Hill - Chapel Hill / United States
Medical and Health Sciences / Epidemiology and Public Health
AD Scientific Index ID: 1542625
person_outline Katie R Mollan's MOST POPULAR ARTICLES
1-) Abacavir–lamivudine versus tenofovir–emtricitabine for initial HIV-1 therapyPE Sax, C Tierney, AC Collier, MA Fischl, K Mollan, L Peeples, C Godfrey, ...New England Journal of Medicine 361 (23), 2230-2240, 20094052009
2-) Atazanavir plus ritonavir or efavirenz as part of a 3-drug regimen for initial treatment of HIV-1: a randomized trialES Daar, C Tierney, MA Fischl, PE Sax, K Mollan, C Budhathoki, ...Annals of internal medicine 154 (7), 445-456, 20113772011
3-) A phase 2a clinical trial of molnupiravir in patients with COVID-19 shows accelerated SARS-CoV-2 RNA clearance and elimination of infectious virusWA Fischer, JJ Eron Jr, W Holman, MS Cohen, L Fang, LJ Szewczyk, ...Science translational medicine 14 (628), eabl7430, 20212482021
4-) Association between efavirenz as initial therapy for HIV-1 infection and increased risk for suicidal ideation or attempted or completed suicide: an analysis of trial dataKR Mollan, M Smurzynski, JJ Eron, ES Daar, TB Campbell, PE Sax, ...Annals of internal medicine 161 (1), 1-10, 20142692014
5-) Molnupiravir, an oral antiviral treatment for COVID-19W Fischer, JJ Eron Jr, W Holman, MS Cohen, L Fang, LJ Szewczyk, ...MedRxiv, 2021.06. 17.21258639, 20212402021